BioCentury | Oct 15, 2020
Finance

Larger stakes, more newcos as Canaan moves to bump up biopharma investments with new $800M fund

...new $800 million fund dedicated to healthcare, Canaan...
...of our healthcare investments —in biopharma,” Canaan...
...20-25% ownership with the initial investment.Within therapeutics, Canaan’s...
BioCentury | Oct 13, 2020
Finance

Oct. 13 Quick Takes: Sovereign wealth fund backs Evotec; plus Canaan, EdiGene, Cedilla, Rappta and Lassogen

...on frequent partnerships with biopharmas around its preclinical platform and services, climbed €0.98 to €23.57 on Tuesday.Canaan...
...is developing lasso peptides for cancer, autoimmunity, pain and inflammation. TargetsPP2A – Protein phosphatase 2A BC Staff Evotec AG Canaan Rappta Cedilla EdiGene chs2020...
BioCentury | Sep 23, 2020
Management Tracks

Gilead BD head Bender takes top job at pediatric cancer start-up Day One

...Bowers to head commercial as Canaan-incubated biotech builds out team   By  Karen Tkach Tuzman, Associate Editor...
...Karen Tkach Tuzman, Associate Editor With ex-Gilead BD head Jeremy Bender on board as CEO, Canaan-incubated...
...him a bird's-eye view of oncology opportunities across industry.Bender succeeds acting CEO Julie Grant, a Canaan...
BioCentury | Sep 18, 2020
Emerging Company Profile

Synthekine launches with $82M to create new cytokine signals

...in nature.  The company, which launched Thursday with an $82 million series A round co-led by Canaan...
...by K. Christopher GarciaUniversity collaborators:  Stanford UniversityCorporate partners: NoneNumber of employees: About 30Funds raised: $82 millionInvestors: Canaan...
BioCentury | Jul 21, 2020
Deals

With deal for Tizona, Gilead places latest bet on cancer immunosuppression

...Other series A investors included Amgen Ventures, Astellas Venture Management and InterWest Partners. Abingworth and Canaan...
BioCentury | May 22, 2020
Emerging Company Profile

With $60M, Canaan-incubated Day One seizes on under-appreciated advances in pediatric cancers

...trial infrastructure to make the former a driving force instead of an afterthought. Incubated by Canaan...
...has approved only 10 new drugs for pediatric cancers in the past 30 years, said Canaan...
...Pharmaceutical Co. Ltd., Sunesis Pharmaceuticals Inc. Number of employees: 22 Funds raised: $62 million Investors: Canaan...
BioCentury | May 20, 2020
Finance

$145M raise positions Rallybio to bring first rare disease program into clinic

...Global Investment Inc. also participated in the untranched round, as did existing investors 5AM Ventures, Canaan...
BioCentury | Mar 18, 2020
Politics, Policy & Law

Bay Area labs pare down to essentials following shelter-in-place directives

...receiving patient samples, running mouse studies to completion and monitoring the health of animal colonies. Canaan...
...countermeasures, is free to all who visit the site. Karen Tkach Tuzman, Associate Editor Stanford University Genentech Inc. twoXAR Inc. Canaan COVID19 COVID-19 shelter-in-place...
BioCentury | Mar 10, 2020
Politics, Policy & Law

We’ve moved on from nude women parties. The progress is much bigger than that.

...Pfizer Ventures, or the Women Who Venture dinner led by Nina Kjellson, general partner at Canaan...
...by a trio of female Chinese biopharma veterans: Samantha Du, Marietta Wu and Stella Xu. Canaan...
...general partner last year -- women now make up five of the seven members of Canaan’s...
BioCentury | Feb 6, 2020
Finance

Feb. 5 Financial Quick Takes: Aimmune gets $200M Nestlé investment; plus Vineti, MaaT, Kezar, Ziopharm, Ikarovec

...the Kite Pharma Inc. unit of Gilead Sciences Inc. (NASDAQ:GILD), as well as existing investors Canaan...
Items per page:
1 - 10 of 281
BioCentury | Oct 15, 2020
Finance

Larger stakes, more newcos as Canaan moves to bump up biopharma investments with new $800M fund

...new $800 million fund dedicated to healthcare, Canaan...
...of our healthcare investments —in biopharma,” Canaan...
...20-25% ownership with the initial investment.Within therapeutics, Canaan’s...
BioCentury | Oct 13, 2020
Finance

Oct. 13 Quick Takes: Sovereign wealth fund backs Evotec; plus Canaan, EdiGene, Cedilla, Rappta and Lassogen

...on frequent partnerships with biopharmas around its preclinical platform and services, climbed €0.98 to €23.57 on Tuesday.Canaan...
...is developing lasso peptides for cancer, autoimmunity, pain and inflammation. TargetsPP2A – Protein phosphatase 2A BC Staff Evotec AG Canaan Rappta Cedilla EdiGene chs2020...
BioCentury | Sep 23, 2020
Management Tracks

Gilead BD head Bender takes top job at pediatric cancer start-up Day One

...Bowers to head commercial as Canaan-incubated biotech builds out team   By  Karen Tkach Tuzman, Associate Editor...
...Karen Tkach Tuzman, Associate Editor With ex-Gilead BD head Jeremy Bender on board as CEO, Canaan-incubated...
...him a bird's-eye view of oncology opportunities across industry.Bender succeeds acting CEO Julie Grant, a Canaan...
BioCentury | Sep 18, 2020
Emerging Company Profile

Synthekine launches with $82M to create new cytokine signals

...in nature.  The company, which launched Thursday with an $82 million series A round co-led by Canaan...
...by K. Christopher GarciaUniversity collaborators:  Stanford UniversityCorporate partners: NoneNumber of employees: About 30Funds raised: $82 millionInvestors: Canaan...
BioCentury | Jul 21, 2020
Deals

With deal for Tizona, Gilead places latest bet on cancer immunosuppression

...Other series A investors included Amgen Ventures, Astellas Venture Management and InterWest Partners. Abingworth and Canaan...
BioCentury | May 22, 2020
Emerging Company Profile

With $60M, Canaan-incubated Day One seizes on under-appreciated advances in pediatric cancers

...trial infrastructure to make the former a driving force instead of an afterthought. Incubated by Canaan...
...has approved only 10 new drugs for pediatric cancers in the past 30 years, said Canaan...
...Pharmaceutical Co. Ltd., Sunesis Pharmaceuticals Inc. Number of employees: 22 Funds raised: $62 million Investors: Canaan...
BioCentury | May 20, 2020
Finance

$145M raise positions Rallybio to bring first rare disease program into clinic

...Global Investment Inc. also participated in the untranched round, as did existing investors 5AM Ventures, Canaan...
BioCentury | Mar 18, 2020
Politics, Policy & Law

Bay Area labs pare down to essentials following shelter-in-place directives

...receiving patient samples, running mouse studies to completion and monitoring the health of animal colonies. Canaan...
...countermeasures, is free to all who visit the site. Karen Tkach Tuzman, Associate Editor Stanford University Genentech Inc. twoXAR Inc. Canaan COVID19 COVID-19 shelter-in-place...
BioCentury | Mar 10, 2020
Politics, Policy & Law

We’ve moved on from nude women parties. The progress is much bigger than that.

...Pfizer Ventures, or the Women Who Venture dinner led by Nina Kjellson, general partner at Canaan...
...by a trio of female Chinese biopharma veterans: Samantha Du, Marietta Wu and Stella Xu. Canaan...
...general partner last year -- women now make up five of the seven members of Canaan’s...
BioCentury | Feb 6, 2020
Finance

Feb. 5 Financial Quick Takes: Aimmune gets $200M Nestlé investment; plus Vineti, MaaT, Kezar, Ziopharm, Ikarovec

...the Kite Pharma Inc. unit of Gilead Sciences Inc. (NASDAQ:GILD), as well as existing investors Canaan...
Items per page:
1 - 10 of 281